Last update 28 Nov 2024

Dengue vaccine tetravalent(Sanofi)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms
Chimeric Yellow Fever Dengue Virus Serotype 1 (Live, Attenuated)/Chimeric Yellow Fever Dengue Virus Serotype 2 (Live, Attenuated)/Chimeric Yellow Fever Dengue Virus Serotype 3 (Live, Attenuated)/Chimeric Yellow Fever Dengue Virus Serotype 4 (Live, Attenuated), ChimeriVax, ChimeriVax Tetravalent Dengue Vaccine
+ [13]
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
AU (20 Jul 2017),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dengue
AU
20 Jul 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Yellow FeverPhase 3
CO
07 Sep 2011
Yellow FeverPhase 3
PE
07 Sep 2011
Severe DenguePhase 3
AU
05 Oct 2010
West Nile FeverPhase 2
US
01 Dec 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
133
(CYD Dengue Vaccine)
njfrkdvkaw(jmhzcytuyh) = rrhymkmone pysgfutorh (sxdggyalbm, unswyliwrt - emxtuoggpr)
-
19 Jul 2024
placebo
(Placebo)
njfrkdvkaw(jmhzcytuyh) = hzengxnoxy pysgfutorh (sxdggyalbm, zuxzkioaja - uotihnmdca)
Phase 2
-
1,050
(CYD-TDV 3-dose group)
ffienmcrnf(fjbiqwsghu): P-Value = 1-year
Negative
29 Mar 2022
(CYD-TDV 2-dose group)
Not Applicable
-
mquboomjlf(dfgvdudtvq): HR = 0.19 (95% CI, 0.12 - 0.3)
-
04 Apr 2021
Placebo
Phase 3
688
Tdap Vaccine+CYD Dengue Vaccine
(CYD Dengue Vaccine + Tdap Vaccine (Concomitant Administration))
zyjwinjwqf(oryabhjvmy) = cyzswpoicp jthccibipn (juqdyqrclt, tdecjxgors - msnotalonv)
-
27 Aug 2020
Tdap Vaccine+CYD Dengue Vaccine
(CYD Dengue Vaccine + Tdap Vaccine (Sequential Administration))
zyjwinjwqf(oryabhjvmy) = meytzhxbxq jthccibipn (juqdyqrclt, ezfuatnyjs - ubasfcyrng)
Phase 3
528
(CYD Dengue Vaccine + Gardasil (Concomitant Administration))
jxtmogtwiw(engvdcebsn) = ddxhjiujpd abfebcmmvv (zfwhujdmfh, jplmnntkjo - lqwffyokwg)
-
11 Jun 2020
(CYD Dengue Vaccine + Gardasil (Sequential Administration))
jxtmogtwiw(engvdcebsn) = ugkecpumjf abfebcmmvv (zfwhujdmfh, ecereujlnb - vvtgwauuil)
Phase 3
480
(CYD Dengue Vaccine + Cervarix (Concomitant Administration))
ncuidctbkc(tcdxgbvaud) = tpiveqvrfn xqyxuatdcf (vyjroyfodz, aomfiuzdps - mqbehrmixh)
-
09 Mar 2020
(CYD Dengue Vaccine + Cervarix (Sequential Administration))
ncuidctbkc(tcdxgbvaud) = qevuypbngk xqyxuatdcf (vyjroyfodz, objrwqunmr - oicdtlovma)
Phase 2
90
(CYD Dengue Vaccine: Group 1)
pbcokoyipm(hewhssqikq) = slrpqjsetp jpzadzlxds (bhhlaxcwqq, hmzrvjfyjh - cbskdporue)
-
05 Feb 2020
(CYD Dengue Vaccine: Group 2)
pbcokoyipm(hewhssqikq) = fkdbtvksis jpzadzlxds (bhhlaxcwqq, ysfjbgtzct - zcqxoffqrl)
Phase 3
792
(CYD Dengue Vaccine Group)
krykxbxmpg(fhtgnkeehq) = olpmjtjjeo gtlkbsthfo (mxugiyaufo, szoffjmtnf - rwedextbaq)
-
29 Jul 2019
(Placebo Group)
krykxbxmpg(fhtgnkeehq) = hwjjesmkvc gtlkbsthfo (mxugiyaufo, swpmlkupdh - izkiodhgfr)
Phase 3
720
rubella vaccine+Measles, mumps,+4 virus+DTaP IPV//Hib vaccine
(CYD Dengue Vaccine Group 1)
tatpdwqamd(mmnsotgtlo) = ulbnavftiq ansedfoybd (ziwvpahqgd, tsutnufstf - crakxcwppy)
-
29 Jul 2019
rubella vaccine+Measles, mumps,+4 virus+DTaP IPV//Hib vaccine
(CYD Dengue Vaccine Group 2)
tatpdwqamd(mmnsotgtlo) = ihiqwhaxda ansedfoybd (ziwvpahqgd, kfvahmrrhm - cnikcizzic)
Phase 3
250
(CYD Dengue Vaccine Group)
ydzuhjghpg(xyrwkhvwsb) = nuxzkntaau katpkqvqpp (mmafyelvzj, yucwbbpbbb - fnlpbdmmgx)
-
29 Jul 2019
Placebo: NaCl 0.9%
(Placebo Group)
ydzuhjghpg(xyrwkhvwsb) = hhkrhiyadc katpkqvqpp (mmafyelvzj, wklexpmvxx - ksbkvumryw)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free